The experimental group:camrelizumab

2 trials

Sponsors

Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Soochow University

Conditions

Biliary tract cancerSolid tumor

Early Phase 1

Camrelizumab combine with gemcitabine and apatinib in the treatment of advanced PD-L1 positive Biliary tract cancer: A Single-arm, open, exploratory clinical study

Active, not recruitingChiCTR2000040181

Jiangsu Provincial People's HospitalBiliary tract cancer

Start: 2020-12-01Updated: 2021-01-18

Phase 4

Real-world study on the safety of camrelizumab in the treatment of solid tumor patients

RecruitingChiCTR2100043527

The First Affiliated Hospital of Soochow UniversitySolid tumor

Start: 2021-03-01Updated: 2021-06-14